Loading…
Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes
BACKGROUND AND OBJECTIVES Stem cells from umbilical cord blood (CB) have increasingly become a viable alternate source of progenitor cells for hematopoietic cell transplantation (HSCT). Cytomegalovirus (CMV) is thought to contribute significantly to HSCT morbidity and mortality. DESIGN AND SETTING R...
Saved in:
Published in: | Hematology/oncology and stem cell therapy 2011, Vol.4 (2), p.67-72 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03 |
---|---|
cites | cdi_FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03 |
container_end_page | 72 |
container_issue | 2 |
container_start_page | 67 |
container_title | Hematology/oncology and stem cell therapy |
container_volume | 4 |
creator | Al Hajjar, Sami Al Seraihi, Amal Al Muhsen, Saleh Ayas, Mouhab Al Jumaah, Suliman Al Jefri, Abdullah Shoukri, Mohamed El Solh, Hassan |
description | BACKGROUND AND OBJECTIVES Stem cells from umbilical cord blood (CB) have increasingly become a viable alternate source of progenitor cells for hematopoietic cell transplantation (HSCT). Cytomegalovirus (CMV) is thought to contribute significantly to HSCT morbidity and mortality. DESIGN AND SETTING Retrospective case-control study in patients at tertiary care center. PATIENTS AND METHODS We determined the incidence, risk factors and outcomes for CMV infection and disease after unrelated cord blood transplantation (UCBT) in children. RESULTS Between 2003 and 2007, 73 pediatric patients underwent UCBT and 68% of recipients were CMV seropositive. The overall incidence of CMV infection, early and late CMV infection was 58.9% (43/73), 62.8% (27/43), and 37.4% (16/43), respectively. In patients with early CMV infection, 6 of 27 (22%) patients progressed to develop CMV end-organ disease including pneumonitis and retinitis. High levels CMV antigenemia ≥ 70 infected cells by pp65 antigenemia assay + PMNs, P = .237) were associated with a higher risk of progression to CMV disease. The development of CMV infections was higher in CMV-seropositive recipients ( P < .001) and in those who developed graft-versus-host-diseases (GVHD) ( P < .001). Other risk factors for CMV infection include the use of high-dose corticosteroids ( P < .001) and older age of the recipient at the time of transplant ( P < .002). Late CMV infection was strongly associated with a previous history of early CMV infection ( P < .001). CONCLUSION CMV infection is a significant complication in UCBT recipients in pediatric patients and is associated with an increase in transplant-related morbidity and mortality. Risk factors for CMV infections after UCBT include GVHD, use of corticosteroids, underlying diseases (hematologic malignancies) and older age. Late CMV infection was strongly associated with a previous history of CMV infection. |
doi_str_mv | 10.5144/1658-3876.2011.67 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_884848634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1658387611500408</els_id><sourcerecordid>884848634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03</originalsourceid><addsrcrecordid>eNp9kMFrHCEYxT2kNGnaP6CX4i2X7FbHGZ1tIVCWJi0EemhyFufzm2Ayq1N1Anvqv15lkxxyKB6Ux3tP3o-Qj5ytO962n7ns-pXolVw3jPO1VEfk5EU7Ju9SumdMCqW6t-S44apRSqoT8ne7z2GHd2YKjy4uiTo_ImQXfH3SxUecTEZLIURLhykES3M0Ps2T8dlUY_XNaJ3J0QGdi4Y-py9FBmfRA57T6NIDHQ3kENM5Nd7SsGQo_6b35M1opoQfnu5Tcnv5_Wb7Y3X96-rn9tv1CoTs1KpRVlrssNnwYTQ98G4UgxqVkRuUiK3CzWBl2cSFBcMsa4RgANAjMqVGJk7J2aF3juHPginrnUuAU1mBYUm679typGiLkx-cEENKEUc9R7czca850xW1rlh1xaorai1VyXx6al-GHdqXxDPnYvh6MGDZ-Ogw6gSusrEuFtzaBvff-otXaZicd2CmB9xjug9L9AWe5jo1munftaEWcN4x1rJe_AMMa6bf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884848634</pqid></control><display><type>article</type><title>Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes</title><source>ScienceDirect</source><creator>Al Hajjar, Sami ; Al Seraihi, Amal ; Al Muhsen, Saleh ; Ayas, Mouhab ; Al Jumaah, Suliman ; Al Jefri, Abdullah ; Shoukri, Mohamed ; El Solh, Hassan</creator><creatorcontrib>Al Hajjar, Sami ; Al Seraihi, Amal ; Al Muhsen, Saleh ; Ayas, Mouhab ; Al Jumaah, Suliman ; Al Jefri, Abdullah ; Shoukri, Mohamed ; El Solh, Hassan</creatorcontrib><description>BACKGROUND AND OBJECTIVES Stem cells from umbilical cord blood (CB) have increasingly become a viable alternate source of progenitor cells for hematopoietic cell transplantation (HSCT). Cytomegalovirus (CMV) is thought to contribute significantly to HSCT morbidity and mortality. DESIGN AND SETTING Retrospective case-control study in patients at tertiary care center. PATIENTS AND METHODS We determined the incidence, risk factors and outcomes for CMV infection and disease after unrelated cord blood transplantation (UCBT) in children. RESULTS Between 2003 and 2007, 73 pediatric patients underwent UCBT and 68% of recipients were CMV seropositive. The overall incidence of CMV infection, early and late CMV infection was 58.9% (43/73), 62.8% (27/43), and 37.4% (16/43), respectively. In patients with early CMV infection, 6 of 27 (22%) patients progressed to develop CMV end-organ disease including pneumonitis and retinitis. High levels CMV antigenemia ≥ 70 infected cells by pp65 antigenemia assay + PMNs, P = .237) were associated with a higher risk of progression to CMV disease. The development of CMV infections was higher in CMV-seropositive recipients ( P < .001) and in those who developed graft-versus-host-diseases (GVHD) ( P < .001). Other risk factors for CMV infection include the use of high-dose corticosteroids ( P < .001) and older age of the recipient at the time of transplant ( P < .002). Late CMV infection was strongly associated with a previous history of early CMV infection ( P < .001). CONCLUSION CMV infection is a significant complication in UCBT recipients in pediatric patients and is associated with an increase in transplant-related morbidity and mortality. Risk factors for CMV infections after UCBT include GVHD, use of corticosteroids, underlying diseases (hematologic malignancies) and older age. Late CMV infection was strongly associated with a previous history of CMV infection.</description><identifier>ISSN: 1658-3876</identifier><identifier>DOI: 10.5144/1658-3876.2011.67</identifier><identifier>PMID: 21727767</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Age Factors ; Anti-Inflammatory Agents - therapeutic use ; Antibodies, Viral - blood ; Case-Control Studies ; Child ; Child, Preschool ; Cord Blood Stem Cell Transplantation ; Cytomegalovirus - immunology ; Cytomegalovirus Infections - epidemiology ; Cytomegalovirus Infections - etiology ; Cytomegalovirus Infections - virology ; Female ; Graft vs Host Disease - drug therapy ; Graft vs Host Disease - etiology ; Hematologic Neoplasms - pathology ; Hematology, Oncology and Palliative Medicine ; Humans ; Incidence ; Infant ; Male ; Methylprednisolone - therapeutic use ; Phosphoproteins - metabolism ; Retrospective Studies ; Risk Factors ; Transplantation, Homologous ; Treatment Outcome ; Viral Matrix Proteins - metabolism ; Virus Activation</subject><ispartof>Hematology/oncology and stem cell therapy, 2011, Vol.4 (2), p.67-72</ispartof><rights>King Faisal Specialist Hospital</rights><rights>2011 King Faisal Specialist Hospital</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03</citedby><cites>FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1658387611500408$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3538,4012,27910,27911,27912,45767</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21727767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al Hajjar, Sami</creatorcontrib><creatorcontrib>Al Seraihi, Amal</creatorcontrib><creatorcontrib>Al Muhsen, Saleh</creatorcontrib><creatorcontrib>Ayas, Mouhab</creatorcontrib><creatorcontrib>Al Jumaah, Suliman</creatorcontrib><creatorcontrib>Al Jefri, Abdullah</creatorcontrib><creatorcontrib>Shoukri, Mohamed</creatorcontrib><creatorcontrib>El Solh, Hassan</creatorcontrib><title>Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes</title><title>Hematology/oncology and stem cell therapy</title><addtitle>Hematol Oncol Stem Cell Ther</addtitle><description>BACKGROUND AND OBJECTIVES Stem cells from umbilical cord blood (CB) have increasingly become a viable alternate source of progenitor cells for hematopoietic cell transplantation (HSCT). Cytomegalovirus (CMV) is thought to contribute significantly to HSCT morbidity and mortality. DESIGN AND SETTING Retrospective case-control study in patients at tertiary care center. PATIENTS AND METHODS We determined the incidence, risk factors and outcomes for CMV infection and disease after unrelated cord blood transplantation (UCBT) in children. RESULTS Between 2003 and 2007, 73 pediatric patients underwent UCBT and 68% of recipients were CMV seropositive. The overall incidence of CMV infection, early and late CMV infection was 58.9% (43/73), 62.8% (27/43), and 37.4% (16/43), respectively. In patients with early CMV infection, 6 of 27 (22%) patients progressed to develop CMV end-organ disease including pneumonitis and retinitis. High levels CMV antigenemia ≥ 70 infected cells by pp65 antigenemia assay + PMNs, P = .237) were associated with a higher risk of progression to CMV disease. The development of CMV infections was higher in CMV-seropositive recipients ( P < .001) and in those who developed graft-versus-host-diseases (GVHD) ( P < .001). Other risk factors for CMV infection include the use of high-dose corticosteroids ( P < .001) and older age of the recipient at the time of transplant ( P < .002). Late CMV infection was strongly associated with a previous history of early CMV infection ( P < .001). CONCLUSION CMV infection is a significant complication in UCBT recipients in pediatric patients and is associated with an increase in transplant-related morbidity and mortality. Risk factors for CMV infections after UCBT include GVHD, use of corticosteroids, underlying diseases (hematologic malignancies) and older age. Late CMV infection was strongly associated with a previous history of CMV infection.</description><subject>Age Factors</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibodies, Viral - blood</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>Cytomegalovirus - immunology</subject><subject>Cytomegalovirus Infections - epidemiology</subject><subject>Cytomegalovirus Infections - etiology</subject><subject>Cytomegalovirus Infections - virology</subject><subject>Female</subject><subject>Graft vs Host Disease - drug therapy</subject><subject>Graft vs Host Disease - etiology</subject><subject>Hematologic Neoplasms - pathology</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Male</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Phosphoproteins - metabolism</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><subject>Viral Matrix Proteins - metabolism</subject><subject>Virus Activation</subject><issn>1658-3876</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kMFrHCEYxT2kNGnaP6CX4i2X7FbHGZ1tIVCWJi0EemhyFufzm2Ayq1N1Anvqv15lkxxyKB6Ux3tP3o-Qj5ytO962n7ns-pXolVw3jPO1VEfk5EU7Ju9SumdMCqW6t-S44apRSqoT8ne7z2GHd2YKjy4uiTo_ImQXfH3SxUecTEZLIURLhykES3M0Ps2T8dlUY_XNaJ3J0QGdi4Y-py9FBmfRA57T6NIDHQ3kENM5Nd7SsGQo_6b35M1opoQfnu5Tcnv5_Wb7Y3X96-rn9tv1CoTs1KpRVlrssNnwYTQ98G4UgxqVkRuUiK3CzWBl2cSFBcMsa4RgANAjMqVGJk7J2aF3juHPginrnUuAU1mBYUm679typGiLkx-cEENKEUc9R7czca850xW1rlh1xaorai1VyXx6al-GHdqXxDPnYvh6MGDZ-Ogw6gSusrEuFtzaBvff-otXaZicd2CmB9xjug9L9AWe5jo1munftaEWcN4x1rJe_AMMa6bf</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Al Hajjar, Sami</creator><creator>Al Seraihi, Amal</creator><creator>Al Muhsen, Saleh</creator><creator>Ayas, Mouhab</creator><creator>Al Jumaah, Suliman</creator><creator>Al Jefri, Abdullah</creator><creator>Shoukri, Mohamed</creator><creator>El Solh, Hassan</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2011</creationdate><title>Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes</title><author>Al Hajjar, Sami ; Al Seraihi, Amal ; Al Muhsen, Saleh ; Ayas, Mouhab ; Al Jumaah, Suliman ; Al Jefri, Abdullah ; Shoukri, Mohamed ; El Solh, Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age Factors</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibodies, Viral - blood</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>Cytomegalovirus - immunology</topic><topic>Cytomegalovirus Infections - epidemiology</topic><topic>Cytomegalovirus Infections - etiology</topic><topic>Cytomegalovirus Infections - virology</topic><topic>Female</topic><topic>Graft vs Host Disease - drug therapy</topic><topic>Graft vs Host Disease - etiology</topic><topic>Hematologic Neoplasms - pathology</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Male</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Phosphoproteins - metabolism</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><topic>Viral Matrix Proteins - metabolism</topic><topic>Virus Activation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al Hajjar, Sami</creatorcontrib><creatorcontrib>Al Seraihi, Amal</creatorcontrib><creatorcontrib>Al Muhsen, Saleh</creatorcontrib><creatorcontrib>Ayas, Mouhab</creatorcontrib><creatorcontrib>Al Jumaah, Suliman</creatorcontrib><creatorcontrib>Al Jefri, Abdullah</creatorcontrib><creatorcontrib>Shoukri, Mohamed</creatorcontrib><creatorcontrib>El Solh, Hassan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hematology/oncology and stem cell therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al Hajjar, Sami</au><au>Al Seraihi, Amal</au><au>Al Muhsen, Saleh</au><au>Ayas, Mouhab</au><au>Al Jumaah, Suliman</au><au>Al Jefri, Abdullah</au><au>Shoukri, Mohamed</au><au>El Solh, Hassan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes</atitle><jtitle>Hematology/oncology and stem cell therapy</jtitle><addtitle>Hematol Oncol Stem Cell Ther</addtitle><date>2011</date><risdate>2011</risdate><volume>4</volume><issue>2</issue><spage>67</spage><epage>72</epage><pages>67-72</pages><issn>1658-3876</issn><abstract>BACKGROUND AND OBJECTIVES Stem cells from umbilical cord blood (CB) have increasingly become a viable alternate source of progenitor cells for hematopoietic cell transplantation (HSCT). Cytomegalovirus (CMV) is thought to contribute significantly to HSCT morbidity and mortality. DESIGN AND SETTING Retrospective case-control study in patients at tertiary care center. PATIENTS AND METHODS We determined the incidence, risk factors and outcomes for CMV infection and disease after unrelated cord blood transplantation (UCBT) in children. RESULTS Between 2003 and 2007, 73 pediatric patients underwent UCBT and 68% of recipients were CMV seropositive. The overall incidence of CMV infection, early and late CMV infection was 58.9% (43/73), 62.8% (27/43), and 37.4% (16/43), respectively. In patients with early CMV infection, 6 of 27 (22%) patients progressed to develop CMV end-organ disease including pneumonitis and retinitis. High levels CMV antigenemia ≥ 70 infected cells by pp65 antigenemia assay + PMNs, P = .237) were associated with a higher risk of progression to CMV disease. The development of CMV infections was higher in CMV-seropositive recipients ( P < .001) and in those who developed graft-versus-host-diseases (GVHD) ( P < .001). Other risk factors for CMV infection include the use of high-dose corticosteroids ( P < .001) and older age of the recipient at the time of transplant ( P < .002). Late CMV infection was strongly associated with a previous history of early CMV infection ( P < .001). CONCLUSION CMV infection is a significant complication in UCBT recipients in pediatric patients and is associated with an increase in transplant-related morbidity and mortality. Risk factors for CMV infections after UCBT include GVHD, use of corticosteroids, underlying diseases (hematologic malignancies) and older age. Late CMV infection was strongly associated with a previous history of CMV infection.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>21727767</pmid><doi>10.5144/1658-3876.2011.67</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1658-3876 |
ispartof | Hematology/oncology and stem cell therapy, 2011, Vol.4 (2), p.67-72 |
issn | 1658-3876 |
language | eng |
recordid | cdi_proquest_miscellaneous_884848634 |
source | ScienceDirect |
subjects | Age Factors Anti-Inflammatory Agents - therapeutic use Antibodies, Viral - blood Case-Control Studies Child Child, Preschool Cord Blood Stem Cell Transplantation Cytomegalovirus - immunology Cytomegalovirus Infections - epidemiology Cytomegalovirus Infections - etiology Cytomegalovirus Infections - virology Female Graft vs Host Disease - drug therapy Graft vs Host Disease - etiology Hematologic Neoplasms - pathology Hematology, Oncology and Palliative Medicine Humans Incidence Infant Male Methylprednisolone - therapeutic use Phosphoproteins - metabolism Retrospective Studies Risk Factors Transplantation, Homologous Treatment Outcome Viral Matrix Proteins - metabolism Virus Activation |
title | Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T00%3A40%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytomegalovirus%20infections%20in%20unrelated%20cord%20blood%20transplantation%20in%20pediatric%20patients:%20incidence,%20risk%20factors,%20and%20outcomes&rft.jtitle=Hematology/oncology%20and%20stem%20cell%20therapy&rft.au=Al%20Hajjar,%20Sami&rft.date=2011&rft.volume=4&rft.issue=2&rft.spage=67&rft.epage=72&rft.pages=67-72&rft.issn=1658-3876&rft_id=info:doi/10.5144/1658-3876.2011.67&rft_dat=%3Cproquest_cross%3E884848634%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3657-27d6de5e291bfa8c15f3b7f7a69e6ee47e9bd627713dca0d02330ccc8ee077f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=884848634&rft_id=info:pmid/21727767&rfr_iscdi=true |